View Article

  • A RETROSPECTIVE STUDY ON EVALUATION OF ANTIBIOTIC UTILIZATION IN RENAL IMPAIRMENT IN A TERTIARY CARE HOSPITAL IN DAKSHINA KANNADA DISTRICT

  • 1Department of Pharmacy Practice, Srinivas College of Pharmacy, Mangalore, Karnataka, INDIA.

Abstract

Renal impairment is the inability of the kidneys to perform their excretory functions, which results in the retention of nitrogenous waste products in the blood. Infectious disease is recognized as an important complication among patients with renal impairment, contributing to excess morbidity and health care costs. Epidemiological research revealed that individuals with end-stage renal disease are more prone to develop infectious complications, which include urinary tract infection, pneumonia, and sepsis. These infections can be managed with the appropriate antibiotics. The objective of the study was to evaluate the utilization patterns of antibiotic in patients with renal impairment. A retrospective study was conducted by screening the medical records of 100 patients who fulfilled the inclusion criteria. Antibiotic utilization was analysed using Microsoft Excel. The mean age of the study participant 59.8 years with 67% male and 33?male. Majority of the patients were diagnosed with CKD (56%). Commonly utilized antibiotics were Inj. Meropenem (21.42%), Inj. Ceftriaxone (12.5%), T. Amoxicillin + Clavulanic acid (9.82%), Inj. Pipracillin + Tazobactam (9.82%).The rational use of antibiotics is critical for optimising clinical outcomes. The most commonly prescribed parenteral antibiotic was Injection Meropenem, while the most commonly prescribed oral antibiotic was Tablet Amoxicillin + Clavulanic acid.

Keywords

Renal impairment, Infections, Antibiotics

Reference

  1. Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Critical Care. 2014; 18(4): 1-8.
  2. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011; 80(1): 17–28.
  3. Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RR. Burden of chronic kidney disease in the general population and high-risk groups in South Asia. PLoS One. 2021; 16(10): 1-19.
  4. Griffin BR, You Z, Holmen J, SooHoo M, Gist KM, Colbert JF, Chonchol M, Faubel S, Jovanovich A. Incident infection following acute kidney injury with recovery to baseline creatinine: A propensity score matched analysis. PLoS One. 2019; 14(6): 1-13.

 

  1. MacRae C, Mercer SW, Guthrie B, Henderson D. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. British Journal of General Practice. 2021; 71(704): 243–9.
  2. Shankar M, Narasimhappa S, Madhura. Urinary tract infection in chronic kidney disease population: A clinical observational study. Cureus. 2021; 13(1): 1-9.
  3. Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang I-Kuan, et al. Risk of Pneumonia Among Patients With Chronic Kidney Disease in Outpatient and Inpatient Settings: a nationwide population-based study. Medicine. 2014; 93(27): 1-4.
  4. Bou Chebl R, Tamim H, Abou Dagher G, Sadat M, Ghamdi G, Itani A, et al. Sepsis in end-stage renal disease patients: are they at an increased risk of mortality? Annals of Medicine. 2021; 53(1): 1737–43.
  5. Hui K, Nalder M, Buising K, Pefanis A, Ooi KY, Pedagogos E, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study. BMC Nephrology. 2017; 18(1): 1-9.
  6. Kourkouta L, Tsaloglidou A, Koukourikos K, Iliadis C, Plati P., Dimitriadou A., History of Antibiotics. Sumerianz Journal of Medical and Healthcare. 2018; 1(2): 51-54.
  7. Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrology. 2015; 16(1): 1-11.
  8. Bábí?ková J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney International. 2017; 91(1):70–85.
  9. Hsu CY, Fang H, Kang Wei Chou, Chen CL, Lee PT, Chung HM. The Clinical Impact of Bacteremia in Complicated Acute Pyelonephritis. The American Journal of the Medical Sciences. 2006; 332(4):175–80.
  10. Dalrymple LS, Mu Y, Nguyen DV, Romano PS, Chertow GM, Grimes B, et al. Risk factors for infection-related hospitalization in in-center hemodialysis. Clinical Journal of  American Society of  Nephrology. 2015; 10(12): 2170–80.
  11. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, Ladipo GOA, Al-Rubaish A. A prospective study of hemodialysis access-related bacterial infections. Journal of Infection and Chemotherapy. 2002; 8(3): 242–6.
  12. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009; 136(5): 1237–48.
  13. Al Himali N, Al Suleimani YM, Al-Zakwani I, Abdelrahman AM. Antibiotics utilization patterns and dosage appropriateness among patients receiving hemodialysis. Saudi Pharmaceutical Journal. 2022; 30(7): 971–8

Photo
K. Anjali
Corresponding author

Department of Pharmacy Practice, Srinivas College of Pharmacy

Viresh K. Chandur, K. Anjali*, Ashitha Ephrem, Ramakrishna Shabaraya A., A Retrospective Study On Evaluation Of Antibiotic Utilization In Renal Impairment In A Tertiary Care Hospital In Dakshina Kannada District, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 11, 214-220. https://doi.org/10.5281/zenodo.10092365

More related articles
A Review On Memory, Alzheimer's Disease Pathophysi...
Priti Patel, Sonali Pradeep Gopale, ...
Development of Herbal Tea Formulation for Function...
Bhavesh Amrute, Amruta Shirude, Onisha Hale, Shruti Kadam, Supriy...
Rosehip (Rosa Canina L.): A Systematic Review of T...
Akash Shembekar, Dinesh Chaple, Rutuja Thakre, Rutuja Bhagat, Nut...
Stimuli-Responsive Lyotropic Liquid Crystalline Systems for Controlled and Targe...
Sajin K. C., Dr. Geetha V. S., Afeefa K. A., Kadeeja P. S., Greeshma V. P., ...
A Comprehensive Review on the Ethnobotanical, Pharmacognostic, Phytochemical, an...
Probal Dhara, Sanchita Podder, Pallabi Mishra, Deepanjan Mondal, Avinaba Samanta, Sumanta Bhattachar...
Related Articles
Perspectives On Cancer Stem Cells: Implications For Future Therapies...
Nidhi Srivastava, Mukesh Ramola, Nidhi Tayal, ...
Comprehensive Review of Dual-Stimuli Responsive In-Situ Gel: Mechanism, Applicat...
Bhuvaneswari. K, Dhanalakshmi. P, Sathish Kumar. D, Kumara Guru. V, ...
Gene Therapy Use In Cancer Treatment ...
Ranjan Kumar Maji, Sheashree Das, Sourav Kole, Anirban Karmakar, Subarna Mandal, ...
Nose-to-Brain Drug Delivery: A Novel Approach Through Solid Lipid Nanoparticles...
Yashashri Deore , Vidhya Thorat , Dr. Pravinkumar Sable , Madhuri Sonawane , Pooja Paliwal , Rohan S...
More related articles
Development of Herbal Tea Formulation for Functional Health Benefits...
Bhavesh Amrute, Amruta Shirude, Onisha Hale, Shruti Kadam, Supriya Jadhav, Ashwini Khaire, Upasani C...
Rosehip (Rosa Canina L.): A Systematic Review of The Plant, Traditional Uses, An...
Akash Shembekar, Dinesh Chaple, Rutuja Thakre, Rutuja Bhagat, Nutan Chahare, Mayuri Durge, ...
Development of Herbal Tea Formulation for Functional Health Benefits...
Bhavesh Amrute, Amruta Shirude, Onisha Hale, Shruti Kadam, Supriya Jadhav, Ashwini Khaire, Upasani C...
Rosehip (Rosa Canina L.): A Systematic Review of The Plant, Traditional Uses, An...
Akash Shembekar, Dinesh Chaple, Rutuja Thakre, Rutuja Bhagat, Nutan Chahare, Mayuri Durge, ...